Video

Diplomat's Specialty Retail Network

Author(s):

Davy James, Managing Editor

Atheer Kaddis, PharmD, senior vice president of Business Development and Sales at Diplomat, discusses retail network services.

Atheer Kaddis, PharmD, senior vice president of Business Development and Sales at Diplomat, discusses retail network services.

Related Videos
Related Content
FDA Approves Prademagene Zamikeracel, First and Only Cell-Based Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa
April 29th 2025

FDA Approves Prademagene Zamikeracel, First and Only Cell-Based Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa

Aislinn Antrim, Managing Editor
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Portrait of a male pharmacist working at the counter in pharmacy | Image Credit: © Zamrznuti tonovi - stock.adobe.com
April 29th 2025

Asembia AXS25: Community Pharmacists Can Optimize Specialty Pharmacy Care

Luke Halpern, Assistant Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Gout tophus, photomicrograph showing amorphous, eosinophilic material with a foreign-body giant cell reaction and inflammation
April 25th 2025

JAK1 Inhibitor NS-229 Granted FDA Orphan Drug Designation to Treat Allergic Autoimmune Condition

Luke Halpern, Assistant Editor
Nasopharyngeal carcinoma -- Image credit: Matthieu | stock.adobe.com
April 24th 2025

FDA Approves Penpulimab-Kcqx for Indications in Nonkeratinizing Nasopharyngeal Carcinoma

Gillian McGovern, Associate Editor